SCHEMBL4040790

SCHEMBL4040790

CCCCNC(=O)C(c1ccc(N(C)C)cc1)C1(c2cccc(OC)c2OC)Nc2ccccc2N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
TP53 P04637 2/20 0.40
MAPT P10636 4/20 0.38
LMNA P02545 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 1/20 0.35
TSHR P16473 2/20 0.35
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
HTR1A P08908 1/20 0.35
DRD4 P21917 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.34
ADRA1D P25100 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040091 0.91 LMNA (0.40) HCRTR1HCRTR2LMNAHPGDTSHR
SCHEMBL4036919 0.90 CNR1 (0.38) ALDH1A1SMN1; SMN2HPGDTSHRADRA1D
SCHEMBL4038953 0.85 HCRTR1 (0.43) HCRTR1HCRTR2TP53MAPTLMNA
SCHEMBL4043313 0.83 TSHR (0.38) HPGDTSHRMEN1KMT2A
SCHEMBL4043634 0.78 CTSD (0.42) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL4039204 0.77 TSHR (0.43) NPC1ALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL4043642 0.76 CTSD (0.46) HCRTR1HCRTR2MAPTLMNAALDH1A1
SCHEMBL4036859 0.75 CTSD (0.40) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL4039555 0.73 USP2 (0.38) TP53MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4037816 0.73 HPGD (0.38) NPC1ALDH1A1RAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed